ConductScience.org, home

Paper33339136

Neuroendocrine and Aggressive-Variant Prostate Cancer.

Spetsieris N and 4 others. Cancers (Basel), 2020. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Neuroendocrine and Aggressive-Variant Prostate Cancer. Papers, record 33339136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33339136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroendocrine and Aggressive-Variant Prostate Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2020-12-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spetsieris NNicholas
2Boukovala MMyrto
3Patsakis GGeorgios
4Alafis IIoannis
5Efstathiou EEleni

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128655541Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.Eur Urol2018https://conductscience.org/library/papers/28655541PubMed
226000489Integrative clinical genomics of advanced prostate cancer.Cell2015https://conductscience.org/library/papers/26000489PubMed
330517936Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis.Urol Int2019https://conductscience.org/library/papers/30517936PubMed
423649003Platinum-based chemotherapy for variant castrate-resistant prostate cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23649003PubMed
530965328Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.Urol Int2019https://conductscience.org/library/papers/30965328PubMed
624705311Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.Am J Surg Pathol2014https://conductscience.org/library/papers/24705311PubMed
717786954Treatment outcomes of small cell carcinoma of the prostate: a single-center study.Cancer2007https://conductscience.org/library/papers/17786954PubMed
826928463Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.Nat Med2016https://conductscience.org/library/papers/26928463PubMed
925601341
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol2015https://conductscience.org/library/papers/25601341PubMed
1026124369Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer.Anticancer Res2015https://conductscience.org/library/papers/26124369PubMed
1116861969Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.Am J Surg Pathol2006https://conductscience.org/library/papers/16861969PubMed
1230337059Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.Eur Urol2019https://conductscience.org/library/papers/30337059PubMed
1328885659The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature.Int J Biol Markers2018https://conductscience.org/library/papers/28885659PubMed
141712661Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.Cancer1991https://conductscience.org/library/papers/1712661PubMed
1529949494Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.N Engl J Med2018https://conductscience.org/library/papers/29949494PubMed
1623850495
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.
Hum Pathol2013https://conductscience.org/library/papers/23850495PubMed
1731774688Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.J Clin Oncol2020https://conductscience.org/library/papers/31774688PubMed
1829297494Neuroendocrine tumors of the prostate.Mod Pathol2018https://conductscience.org/library/papers/29297494PubMed
1928059767Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.Science2017https://conductscience.org/library/papers/28059767PubMed
2011958660Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice.Arch Pathol Lab Med2002https://conductscience.org/library/papers/11958660PubMed

See all 102 referencesDownload CSV of references

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42897296Rare prostate cancer histologies: detection, characteristics and treatment.Nat Rev Urol2026https://conductscience.org/library/papers/42897296PubMed
42883702The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases.Int J Mol Sci2026https://conductscience.org/library/papers/42883702PubMed
42795739Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis.J Clin Med2026https://conductscience.org/library/papers/42795739PubMed
42739268The Prognostic Role of the Lung Immune Prognostic Index in Neuroendocrine Prostate Cancer: A Multicenter Retrospective Study.Diagnostics (Basel)2026https://conductscience.org/library/papers/42739268PubMed
42569009Urethral Metastasis of Therapy-Induced Neuroendocrine Prostate Cancer Successfully Managed With Chemoradiotherapy: A Case Report.IJU Case Rep2026https://conductscience.org/library/papers/42569009PubMed
42527846DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.Drugs2026https://conductscience.org/library/papers/42527846PubMed
42423955
Platinum-based chemotherapy in metastatic castration-resistant prostate cancer: a narrative review and dual stratification framework based on HRR genotype and aggressive-variant/neuroendocrine phenotype.
Int Urol Nephrol2026https://conductscience.org/library/papers/42423955PubMed
42346954LRRC8D Suppresses Prostate Cancer Growth and Enhances Platinum Sensitivity via Modulation of CAV-1/STAT3 Signaling.Membranes (Basel)2026https://conductscience.org/library/papers/42346954PubMed
42339116Case Report: a rare case of small cell carcinoma of the prostate.Front Oncol2026https://conductscience.org/library/papers/42339116PubMed
41768965Undifferentiated Castration-Resistant Prostate Cancer Successfully Treated With Carboplatin and Paclitaxel.Case Rep Urol2026https://conductscience.org/library/papers/41768965PubMed
41718350Transcriptomic Insights into lncRNA-miRNA-mRNA Networks Regulating Angiogenesis and Metastasis in Prostate Cancer.BioTech (Basel)2026https://conductscience.org/library/papers/41718350PubMed
41584790Clonal selection of pre-existing neuroendocrine component in prostate cancer during androgen receptor signaling inhibitor therapy: A case report.Urol Case Rep2026https://conductscience.org/library/papers/41584790PubMed
41547728Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer.BMC Urol2026https://conductscience.org/library/papers/41547728PubMed
41097640EZH2 Dysregulation and Its Oncogenic Role in Human Cancers.Cancers (Basel)2025https://conductscience.org/library/papers/41097640PubMed
40805284Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management.Cancers (Basel)2025https://conductscience.org/library/papers/40805284PubMed
40788171Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress.Clin Cancer Res2025https://conductscience.org/library/papers/40788171PubMed
40699451Reappraisal of Neuroendocrine Tumor Classification of the Prostate Gland: Translating Molecular Insights into Clinical Practice.Endocr Pathol2025https://conductscience.org/library/papers/40699451PubMed
40641143Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).Oncol Rep2025https://conductscience.org/library/papers/40641143PubMed
40525978Update on Liquid Biopsy.Radiology2025https://conductscience.org/library/papers/40525978PubMed
40421291A prognostic model for highly aggressive prostate cancer using interpretable machine learning techniques.Front Med (Lausanne)2025https://conductscience.org/library/papers/40421291PubMed

See all 56 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CALCA796PubTator's text mininghttps://conductscience.org/library/genes/796NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
CHGA1113PubTator's text mininghttps://conductscience.org/library/genes/1113NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
DLL310683PubTator's text mininghttps://conductscience.org/library/genes/10683NCBI Gene
ENO22026PubTator's text mininghttps://conductscience.org/library/genes/2026NCBI Gene
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
GRP2922PubTator's text mininghttps://conductscience.org/library/genes/2922NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
MLH14292PubTator's text mininghttps://conductscience.org/library/genes/4292NCBI Gene
MLH327030PubTator's text mininghttps://conductscience.org/library/genes/27030NCBI Gene
MSH24436PubTator's text mininghttps://conductscience.org/library/genes/4436NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33339136

GET https://conductscience.org/api/papers/v1/33339136/references?page=2